PMID: 44909Jan 1, 1979

Cefaclor: clinical and bacteriological evaluation in 45 cases

Postgraduate Medical Journal
R Gómez-LusA Clavel

Abstract

This report deals with studies of the effectiveness, tolerance and toxicity of cefaclor in the treatment of 45 patients with urinary tract infections (40 cases) and pneumonia (5 cases) caused by susceptible pathogens. Cefaclor was administered orally in a dosage of 1 to 3 g per day for 7 to 11 days. Clinical and laboratory examinations were performed before, during, at the end of treatment, and 4 weeks later in cases of urinary infection. All 5 patients with pneumonia and bronchopneumonia were cured. Clinical and bacteriological cures were obtained in 28 (70%) of the 40 cases of urinary tract infections. Identification and typing of microorganisms, disk sensitivity tests, minimal inhibitory concentrations and cefaclor blood levels also were determined.

Related Concepts

Lilly 99638
Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer
Paracolobactrum
Experimental Lung Inflammation
Staphylococcus aureus
Streptococcus pneumoniae
Urinary Tract Infection

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

The Japanese journal of antibiotics
M HoriF Hashimoto
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
K AsvanichD Tanphaichitra
© 2021 Meta ULC. All rights reserved